Shree Ganesh Bio-Tech P/E Ratio
Current P/E Ratio
48.0
High Valuation
Very High - High growth expectations or significantly overvalued
Shree Ganesh Bio-Tech (SHREEGANES) P/E ratio is 48.0 (High), EPS (TTM) ₹0.01, current price ₹0.48 on BSE — Very High - High growth expectations or significantly overvalued. For live price, revenue and the complete fundamental profile, see Shree Ganesh Bio-Tech share price screener.
Current Valuation Metrics
P/E Ratio
48.0
Current Price
₹0.48
EPS (TTM)
₹0.01
Exchange
BSE
Valuation Signal
Signal
Overvalued
Sector Context
Sector Average
56.77
Sector Median
32.06
Sector Rank
#11 of 200
Sector Percentile
5.5%
SHREEGANES P/E Ratio — Valuation Signal & Historical Context
Shree Ganesh Bio-Tech P/E 48.0 — signal: Overvalued. Also explore Shree Ganesh Bio-Tech stock price data download to track price trends across different timeframes.
- Stock appears overvalued with PE of 48.0, suggesting caution for new investments
- Trading at discount to sector average PE of 56.77
SHREEGANES vs Healthcare Peers — P/E Ratio Comparison
Shree Ganesh Bio-Tech P/E 48.0 vs Healthcare average 56.77, median 32.06 — range 1.99–747.21.
Sector Average
56.77
Sector Median
32.06
Lowest P/E
1.99
Highest P/E
747.21
Companies
200
| Company | Symbol | P/E Ratio | Market Cap (₹ Cr) | Valuation |
|---|---|---|---|---|
| Sunrest Lifescience | SUNREST | 1.99 | ₹66 | Low |
| Murae Organisor | MURAE | 2.86 | ₹41 | Low |
| Colinz Laboratories | COLINZ | 3.27 | ₹9 | Low |
| Phaarmasia | PHRMASI | 3.41 | ₹59 | Low |
| Sun Pharma Advanced Rese… | SPARC | 4.03 | ₹6,361 | Low |
| Dipna Pharmachem | DPL | 4.65 | ₹12 | Low |
| JFL Life Sciences | JFLLIFE | 4.95 | ₹67 | Low |
| Shelter Pharma | SHELTER | 5.71 | ₹56 | Low |
| GKB Ophthalmics | GKB | 5.9 | ₹33 | Low |
| Kabra Drugs | KABRADG | 6.29 | ₹49 | Low |